跳转至内容
Merck
所有图片(2)

Key Documents

View All Documentation

RAB0222

Sigma-Aldrich

人IFN γ ELISA试剂盒

for serum, plasma, cell culture supernatant and urine

别名:

IFN-gamma, Interferon gamma

登录查看公司和协议定价
所有图片(2)

About This Item

分類程式碼代碼:
41116158
NACRES:
NA.32

物種活性

human

包裝

kit of 96 wells (12 strips x 8 wells)

技術

ELISA: suitable
capture ELISA: suitable

輸入

sample type plasma
sample type urine
sample type serum
sample type cell culture supernatant(s)

assay range

inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 15 pg/mL
standard curve range: 20.6-15000 pg/mL

檢測方法

colorimetric

運輸包裝

wet ice

儲存溫度

−20°C

基因資訊

human ... IFNG(3458)

相关类别

一般說明

人IFN- ELISA（酶联免疫吸附测定）试剂盒是一种体外酶联免疫吸附测定，用于定量测量血清、血浆、细胞培养上清液和尿液中的人IFN-。

免疫原

重组人IFN-γ

應用

仅供研究使用。不用于诊断操作。
请参阅随附常规ELISA试剂盒 操作步骤（夹心式、竞争性 & 间接ELISA）
人IFN γ ELISA试剂盒已用于测定细胞培养上清液 和巨噬细胞中的干扰素-γ水平。

生化／生理作用

IFNG（干扰素-γ）是一种2型干扰素，由Th（T辅助细胞）-1淋巴细胞、CD8细胞毒性淋巴细胞、自然杀伤（NK）细胞和自然杀伤T（NKT）细胞产生。它在天然免疫和获得性免疫应答中发挥重要作用，并有助于防御细菌感染、二型酵母和一些病毒感染。IFNG高表达常见于许多自身免疫性疾病，如系统性红斑狼疮、Sjögren综合征、炎症性肠病和多发性硬化症。

其他說明

本产品提供样本检验报告。
请在批号对应的文本框中输入样品 一词。

试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书
  • RABELADAELISA 1X Assay/Sample Diluent Buffer A (Item D1)化学品安全说明书
  • RABELADBELISA 5X Assay/Sample Diluent Buffer B (Item E1)化学品安全说明书
  • RABSTOP3ELISA Stop Solution (Item I)化学品安全说明书
  • RABTMB3ELISA Colorimetric TMB Reagent (HRP Substrate, Item H)化学品安全说明书
  • RABWASH420X Wash Buffer (Item B)化学品安全说明书

象形圖

Corrosion
GHS05

訊號詞

Warning

危險聲明

H290

防範說明

P234 - P390

危險分類

Met. Corr. 1

儲存類別代碼

8A - Combustible corrosive hazardous materials

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Benjamin J Murdock et al.
Journal of immunology (Baltimore, Md. : 1950), 193(8), 4107-4116 (2014-09-17)
The potent immunoregulatory properties of IL-10 can counteract protective immune responses and, thereby, promote persistent infections, as evidenced by studies of cryptococcal lung infection in IL-10-deficient mice. To further investigate how IL-10 impairs fungal clearance, the current study used an
Samuel T Haile et al.
Cancer immunology research, 2(7), 610-615 (2014-05-14)
Tumor cells use various methods of immunosuppression to overcome antitumor immunity. One such method is that of programmed death ligand-1 (PD-L1 or B7-H1), which upon binding its receptor PD-1 on T cells triggers apoptotic death of the activated T cells.
Yang Sun et al.
Nature communications, 5, 5225-5225 (2014-10-11)
T-cell activation is critical for successful immune responses and is controlled at multiple levels. Although many changes of T-cell receptor-associated signalling molecules affect T-cell activation, the transcriptional mechanisms that control this process remain largely unknown. Here we find that T
Yong-Chen Lu et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(13), 3401-3410 (2014-07-06)
Cancer immunotherapy with adoptive transfer of tumor-infiltrating lymphocytes (TIL) represents an effective treatment for patients with metastatic melanoma, with the objective regressions in up to 72% of patients in three clinical trials. However, the antigen targets recognized by these effective
Shuxian Hu et al.
PloS one, 9(8), e105219-e105219 (2014-08-19)
The ability of neural stem/progenitor cells (NSCs) to self-renew, migrate to damaged sites, and differentiate into neurons has renewed interest in using them in therapies for neurodegenerative disorders. Neurological diseases, including viral infections of the brain, are often accompanied by
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门